.Attribute Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin resulted in strengthened progression-free and total survival, bring about FDA commendation and a new procedure alternative for individuals.